购物车
全部删除
您的购物车当前为空
hAChE-IN-9(compound 7i)是一种针对人乙酰胆碱酯酶(hAChE)的选择性抑制剂,其对AChE和BChE的抑制活性IC50值分别为0.05 μM 和2.85 μM。该化合物可有效转变有毒的Aβ寡聚物为无毒形式,并展现出抗氧化和神经保护特性,有助于缓解Aβ诱导的毒性。此外,hAChE-IN-9也被用于阿尔兹海默病的相关研究中。
hAChE-IN-9(compound 7i)是一种针对人乙酰胆碱酯酶(hAChE)的选择性抑制剂,其对AChE和BChE的抑制活性IC50值分别为0.05 μM 和2.85 μM。该化合物可有效转变有毒的Aβ寡聚物为无毒形式,并展现出抗氧化和神经保护特性,有助于缓解Aβ诱导的毒性。此外,hAChE-IN-9也被用于阿尔兹海默病的相关研究中。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
hAChE-IN-9 相关产品
| 产品描述 | hAChE-IN-9 (compound 7i) is a selective inhibitor of human acetylcholinesterase (hAChE), showcasing inhibition activities with IC50 values of 0.05 μM for AChE and 2.85 μM for BChE. This compound modulates toxic Aβ oligomers into non-toxic forms and offers antioxidant and neuroprotective effects against Aβ-induced toxicity. hAChE-IN-9 is employed in the study of Alzheimer's disease. |
| 靶点活性 | AChE (human):0.05 μM, BCHE (human):2.85 μM |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容